Selank

Selank (TP-7)

Also known as: TP-7

Low Risk

CognitiveSleep & WellnessImmune Support

A synthetic analog of the immunomodulatory peptide tuftsin. Registered as anxiolytic in Russia. Modulates GABAergic and serotonergic pathways for calm without sedation.

Benefits

Reduces anxiety without sedation or cognitive impairment

Improves emotional stability and stress resilience

Enhances immune function

Nootropic effects (memory, learning)

Modulates GABA and serotonin pathways

Helpful for withdrawal support

Side Effects & Risks

Generally very well toleratedmild

Mild fatigue in some usersmild

Nasal irritation (intranasal route)mild

Dosing Information

Typical Dose

250-1000 mcg/day

Administration

Intranasal spray or subcutaneous injection

Cycle Length

5-14 day cycles

Notes

Morning administration recommended. Published protocols often use 750-1000 mcg/day. Effects build over 4-12 weeks.

Legal Status

FDA Status

Not FDA-approved in USA

Availability

Removed from Category 2 Sept 2024; registered in Russia

WADA Status

Not currently banned

Evidence

Evidence LevelLow-Moderate

Decades of research in Russia with multiple published studies. No Western RCTs. Registered as anxiolytic in Russia. Effectively banned for athletes under WADA S0 (non-approved substances) despite not being explicitly listed.